Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation.
about
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes.Identification and functional analysis of acute myeloid leukemia susceptibility associated single nucleotide polymorphisms at non-protein coding regions of RUNX1.Targets of opportunity for precision medicineThe molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.
P2860
Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Runx1 deficiency permits granu ...... impairs subsequent maturation.
@en
Runx1 deficiency permits granu ...... impairs subsequent maturation.
@nl
type
label
Runx1 deficiency permits granu ...... impairs subsequent maturation.
@en
Runx1 deficiency permits granu ...... impairs subsequent maturation.
@nl
prefLabel
Runx1 deficiency permits granu ...... impairs subsequent maturation.
@en
Runx1 deficiency permits granu ...... impairs subsequent maturation.
@nl
P2093
P2860
P356
P1433
P1476
Runx1 deficiency permits granu ...... impairs subsequent maturation.
@en
P2093
P2860
P2888
P356
10.1038/ONCSIS.2013.41
P577
2013-11-04T00:00:00Z